Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FAITH MEDICAL CENTER P.C.

NPI: 1992947766 · CHARLOTTE, NC 28211 · Addiction Medicine (Psychiatry & Neurology) Physician · NPI assigned 03/25/2009

$3.25M
Total Medicaid Paid
172,504
Total Claims
106,596
Beneficiaries
132
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialONAFOWOKAN, JOEL (MEDICAL DIRECTOR)
NPI Enumeration Date03/25/2009

Related Entities

Other providers sharing the same authorized official: ONAFOWOKAN, JOEL

ProviderCityStateTotal Paid
HOPE MILLS URGENT CARE & MEDICAL CLINIC, PLLC HOPE MILLS NC $1.26M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,953 $344K
2019 8,082 $362K
2020 9,978 $440K
2021 24,698 $766K
2022 27,625 $454K
2023 38,564 $383K
2024 52,604 $501K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 13,666 8,596 $689K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,681 2,716 $618K
99199 Unlisted special service, procedure or report 66,983 37,868 $430K
98968 6,946 1,049 $348K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,883 5,481 $329K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,393 5,751 $285K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 432 246 $63K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,962 1,499 $43K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 547 316 $42K
86003 215 186 $37K
84443 Thyroid stimulating hormone (TSH) 2,038 1,548 $25K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 852 597 $24K
80061 Lipid panel 2,858 2,107 $23K
86328 743 524 $22K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 156 92 $21K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 117 19 $18K
36410 2,568 1,679 $17K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,708 2,084 $16K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,379 593 $16K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 95 75 $13K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 125 81 $12K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 136 129 $11K
83036 Hemoglobin; glycosylated (A1C) 1,930 1,383 $10K
99407 740 432 $9K
87541 480 275 $9K
87581 481 275 $9K
87486 481 275 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 638 560 $8K
71046 Radiologic examination, chest; 2 views 389 343 $8K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 100 77 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,362 749 $7K
81002 4,561 3,039 $6K
82948 4,043 2,590 $6K
99406 958 684 $6K
87498 348 201 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 374 299 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 88 47 $4K
92567 375 337 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 76 57 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 104 64 $3K
90472 Immunization administration, each additional vaccine (list separately) 88 63 $2K
95923 63 44 $2K
36415 Collection of venous blood by venipuncture 1,157 966 $2K
90792 Psychiatric diagnostic evaluation with medical services 32 26 $2K
90460 Immunization administration through 18 years of age via any route, first or only component 133 87 $2K
92551 695 522 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 18 16 $1K
94070 44 38 $1K
87660 117 67 $1K
83880 52 41 $1K
94060 44 38 $1K
87510 117 67 $1K
93000 145 113 $1K
87631 20 17 $1K
99401 190 101 $1K
82947 450 322 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 129 93 $999.57
G9919 Screening performed and positive and provision of recommendations 27 22 $657.30
99173 843 661 $604.55
83874 52 41 $525.69
87480 59 25 $494.80
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 23 20 $486.57
87641 23 20 $486.57
82553 53 41 $469.92
87640 23 20 $456.33
84484 52 41 $400.29
85379 52 41 $374.88
93923 45 18 $366.52
88142 19 12 $299.88
95943 35 20 $241.00
80305 45 35 $214.35
81025 58 37 $203.42
96110 Developmental screening, with scoring and documentation, per standardized instrument 21 19 $149.14
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 74 40 $143.90
3044F 402 286 $100.21
92552 38 34 $80.75
96127 26 14 $65.20
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 791 506 $51.15
99490 Ccm add 20min 28 15 $48.60
90656 14 14 $42.00
90688 149 102 $18.22
J1885 Injection, ketorolac tromethamine, per 15 mg 42 24 $16.16
G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) 15 13 $12.14
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 3,866 2,461 $2.50
1160F 1,450 1,072 $0.29
3074F 2,019 1,489 $0.28
3079F 1,458 1,117 $0.26
3077F 1,185 862 $0.21
3078F 1,803 1,354 $0.20
3080F 878 631 $0.17
3075F 922 718 $0.13
1159F 160 123 $0.05
G8420 Bmi is documented within normal parameters and no follow-up plan is required 717 486 $0.00
1036F 1,746 1,116 $0.00
4000F 1,321 949 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 342 238 $0.00
3008F 1,217 914 $0.00
1034F 119 102 $0.00
99000 198 119 $0.00
80324 43 38 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 48 34 $0.00
80367 43 38 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 47 33 $0.00
80368 43 38 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 55 38 $0.00
80359 43 38 $0.00
80358 43 38 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 58 32 $0.00
80353 43 38 $0.00
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 41 29 $0.00
80363 43 38 $0.00
80349 43 38 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 2,848 1,814 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 267 183 $0.00
80356 43 38 $0.00
80348 43 38 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 120 88 $0.00
G0444 Annual depression screening, 5 to 15 minutes 78 49 $0.00
80369 43 38 $0.00
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 19 12 $0.00
90649 43 30 $0.00
80354 43 38 $0.00
80373 43 38 $0.00
90658 15 13 $0.00
G8482 Influenza immunization administered or previously received 18 12 $0.00
80360 43 38 $0.00
4004F 132 114 $0.00
80361 43 38 $0.00
90734 26 15 $0.00
80365 43 38 $0.00
83992 43 38 $0.00
80346 43 38 $0.00